Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...

The heads of national HIV organizations have stepped up their advocacy, asking Congress to oppose cuts in President Donald ...

The administration’s proposed budget for HIV prevention represents a 78 percent reduction compared to last fiscal year.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV care and research in the United States, according to Carl Schmid, executive ...